The nucleus incertus (NI) is a small cluster of brainstem neurons presumed to play a role in stress responses. We show that swim stress (normal water: 30 min and cold water: 20 min) and elevation stress robustly induced c-Fos expression in the NI and significantly suppressed long-term potentiation (LTP) in the hippocampo-medial prefrontal cortical (HP-mPFC) pathway. To examine whether activation of CRF 1 receptors in the NI plays a role in the suppression of HP-mPFC LTP, antalarmin, a specific CRF 1 receptor antagonist, was infused directly into the NI either before presentation of (1) elevation stress or (2) high frequency stimulation. As predicted, the intra-NI infusion of antalarmin reversed the elevation stress-induced suppression of LTP in the HP-mPFC pathway. This report suggests that the CRF 1 receptor in the NI contributes to stress-related impairment in plasticity of the HP-mPFC pathway. The findings suggest that the NI-HP-mPFC is a stress responsive circuit in the rodent brain.
Introduction
The nucleus incertus (NI) is a group of neurons in the caudal part of mammalian brain stem. Corticotropin releasing factor type 1 (CRF 1 ) receptor expression in the NI not only defines the precise localisation of this neuronal group, but also hints at its role in stress responses (Rivest et al., 1995; Tanaka et al., 2005) . The NI, apart from being the principal source of relaxin-3 and the epicentre of the brain relaxinergic system, is GABAergic (Ma et al., 2007) in nature and expresses various neurotransmitters and peptides [for review see (Ryan et al., 2011)] . NI neurons respond to stressors such as immobilisation or forced swimming as is evident from elevated c-Fos (Tanaka et al., 2005) and relaxin-3 mRNA (Banerjee et al., 2010) expression, respectively. Recently, we have shown that CRF 1 receptor positive NI neurons project to the medial prefrontal cortex (mPFC) and that infusion of CRF peptide (into the NI) or electrical stimulation of the NI inhibits neuronal firing in the medial prefrontal cortex (mPFC) and impairs long-term potentiation (LTP) in the hippocampo-medial prefrontal cortical (HP-mPFC) pathway (Farooq et al., 2013) . Furthermore, elevation stress is known to impair LTP in the HP-mPFC pathway (Rocher et al., 2004) . Here we investigated the effects of stressors -cold water swim (20 min), swim (30 min), and elevation (30 min) -on c-Fos expression in the NI and LTP in the HP-mPFC pathway. In addition, the effect of infusion of antalarmin, a selective CRF 1 receptor antagonist (Webster et al., 1996) , into the NI (prior to presentation of stress or high frequency stimulation) on the elevation stress-induced impairment of HP-mPFC LTP was studied in order to elucidate the contribution of the NI in stress-induced impairment of HP-mPFC LTP.
Experimental procedures

Animals
All procedures on animals were approved by the Institutional Animal Care and Use Committee (IACUC), National University of Singapore, and were carried out in accordance with the Guidelines on the Care and Use of Animals for Scientific Purposes developed by the National Advisory Committee For Laboratory Animal Research, Singapore; the European Communities Council Directive of 24 November 1986 (86/609/EEC); and the Guidelines laid down by the NIH in the US regarding the care and use of animals for experimental procedures. Adult male SpragueDawley rats (290-350 g) were obtained from the Centre for Animal Resources (CARE), National University of Singapore. Pairs of rats were housed in individually ventilated cages in a housing room that was temperature-controlled (23 ± 1 • C) and maintained on a 12-h light-dark cycle (07:00-19:00 h) with free access to food and water. They were acclimatised for at least 3 days before the initiation of experiments.
Drugs and chemicals
Ketamine (Parnell Manufacturing Pty Ltd; Alexandria, NSW, Australia), xylazine (Ilium Xylazil, Troy Laboratories Pty Ltd; Glendenning, NSW, Australia), enrofloxacin (Baytril 5%, Bayer Health Care; Seoul, Korea) and carprofen (Carprieve, Norbrook Laboratories (GB), Ltd; Carlisle, UK) were freshly prepared in sterile isotonic saline before use. Antalarmin hydrochloride (Tocris, UK) was dissolved in sterile 0.9% saline by sonication at 60 • C for 10-15 min. Pentobarbital (Valabarb) was purchased from Jurox Pty Ltd, Australia.
Stress protocols
Rats were subjected to three kinds of stress protocols published (Rocher et al., 2004; Tan et al., 2004) elsewhere, and adopted with slight modifications as described below. In the cold swim stress, rats were individually forced to swim for a duration of 20 min in a semitransparent cylindrical plastic container (Diameter: 32 cm and height: 42 cm) filled with water (18 • C) to a depth of 30 cm. The swim stress procedure was similar to the cold swim stress condition except for the duration (30 min) of stress and the temperature (24-25 • C) of water. After swim stress (either variants), the rats were dried with a towel and returned to their home cages. In the elevation stress protocol, the rats were placed on an unsteady elevated (1 m above ground level) transparent Perspex glass platform (20 cm × 20 cm) for 30 min with two powerful lamps (90 cm apart) focusing on the rats. Non-stressed control rats were kept in their home cages for 30 min before subsequent procedures. The stressed (and non-stressed) rats were subjected to electrophysiological procedures or sacrificed after 2 h for the c-Fos study ( Fig. 1A and B) as described below.
Surgery
One cohort of rats underwent cannula implantation surgery to facilitate intra-NI infusion antalarmin prior to stress procedures. Briefly, the rats were anaesthetised with the anaesthetic combination, ketamine (75 mg/kg) and xylazine (10 mg/kg), mounted on a stereotaxic frame and homeothermically maintained throughout the aseptic procedure. Following a midline sagittal incision, burr holes were drilled above the NI (AP: −9.7 mm and ML: 0). A guide cannula with a dummy stylette was lowered to a DV coordinate of 7.5 mm. The cannula was held in place with dental cement and anchoring skull screws. Rats were sutured, returned to the homecage and they received analgesic and antibiotic injections for the first five days of the 7-day rehabilitation period. During the experimentation, the dummy cannula was replaced by infusion cannula (with 1 mm projection from the guide cannula) that was connected to the microsyringe to facilitate administration of antalarmin hydrochloride or 0.9% saline. 
Electrophysiology
Control and stressed rats were anaesthetised with an intraperitoneal injection of chloral hydrate (420 mg/kg) and mounted on a stereotaxic frame. The lateral tail was cannulated to facilitate administration of maintenance doses of chloral hydrate. Burr holes were drilled to target the mPFC (AP: 3.3 mm, ML: ±0.8 mm and DV: −4.2-4.7 mm from the skull) and CA1/ventral subiculum (VS) of the hippocampal formation (AP: −6.3, ML: ±5.5 and DV: −4-7.2 mm from the skull). A stainless steel monopolar electrode (SNE-300; Kopf Instruments) with a recording tip of length 250 m and diameter of 100 m was lowered into the mPFC, and a bipolar stainless steel stimulating electrode (SNE-100; Kopf Instruments, Tujunga, CA, USA) with diameters of 100 and 250 m (central and outer, respectively) and a tip separation of 500 m was lowered into the CA1/VS. The negative going peak of the evoked response in the mPFC due to test stimulus (250-350 A every 15 s) presentation at the CA1/VS stimulation was obtained and maximised by gently adjusting the DV coordinates. Following the detection of the maximal response the electrodes were left in place for 10 min for stabilisation. An input-output curve (100-450 A) was constructed for the evoked response and the stimulus intensity was set at 60% of the maximum response for the LTP experiment. The experimental protocol consisted of (i) 30 min of baseline recording followed by (ii) ten trains of high-frequency stimulation (HFS; 50 pulses, 250 Hz) with inter-train interval of 10 s and finally (iii) 90 min of post-HFS recording. Following the electrophysiological recordings, pontamine sky blue was infused into the NI to aid in the postmortem verification of the antalarmin administration site.
Intra-NI infusion of antalarmin
Antalarmin hydrochloride (0.25 g/0.1 l) or an equal volume of 0.9% saline was infused into the NI using the infusion cannula and the Hamilton microsyringe assembly, over 30 s. The cannula was left in place for 1 min before gradual withdrawal. The effect of antalarmin was assessed in 2 conditions (Fig. 1B): (1) infusion 10 min prior to elevation stress and (2) 5 min prior to high frequency stimulation (post elevation stress).
Postmortem processing
Rats exposed to appropriate procedures as described above were sacrificed with an overdose of pentobarbital 2 h after presentation of stress or soon after the electrophysiological recordings. Transcardial perfusion with saline (0.9%) was followed by paraformaldehyde (4% in 0.1 M phosphate buffer) and the brain was harvested. Following post-fixation in paraformaldehyde, the brain was saturated in sucrose (30%) and subjected to cryosectioning to (1) detect cannula and/or electrode positions in the regions of manipulation or (2) detect c-Fos like immunoreactivity in the NI. Animals with incorrect cannula positions were rejected from analysis (Fig. 1C) .
c-Fos Immmunofluorescence labelling
Six to eight serial sections (40 m) of NI per brain sampled throughout the NI were blocked with goat serum and incubated with anti-c-Fos primary antibody (PC38, Calbiochem, Merck) overnight at 4 • C. The sections were then incubated with secondary antibody Alexa Fluor 555 goat anti-rabbit (1:200; Invitrogen) and mounted with ProLong Gold Antifade reagent with DAPI (P36935, Molecular Probes, Invitrogen). The c-Fos immunoreactivity was imaged with a fluorescence microscope.
Counting of c-Fos positive cells
The counting of c-Fos positive cells were carried out according to previously published procedures Verma et al., 2007) . Briefly, the numbers of c-Fos positive NI neurons were counted after merging with DAPI stained images of the same section for 6-8 sections per brain. Counting was restricted to a region of interest, a triangular area (generated in ImageJ) that encompassed the entire CRF 1/2 receptor immunostained NI in a section where the NI was largest in the mediolateral and dorsoventral aspects. The values were represented by the number of c-Fos positive NI neurons per square millimeter.
Statistics
The data from the c-Fos study was subjected to one-way ANOVA followed by post hoc Tukey's HSD multiple comparisons test. The evoked potential data of 5 min time periods of averaged fieldevoked postsynaptic potentials (fESPs), was presented as mean percentage ± SEM and normalized to the baseline for each group. To demonstrate induction of LTP in the non-stressed group, a repeated measures ANOVA for the within-subject effect of time was conducted. To investigate treatment effects, 30 min time periods of the same data (30 min baseline and 0-30 min, 30-60 min and 60-90 min post-HFS) were subjected to two-way ANOVA with time as a repeated measure (within subjects) and treatment groups analysed between subjects (Lim et al., 2010) . To determine the treatment effects at various time points (T BL , T 0-30 , T 31-60 , and T 61-90 ) the data was subjected to two-tailed Student's t-test (for the comparison of different kinds of stress) or one-way ANOVA (for antalarmin effects). All comparisons were made against the non-stressed group. If significance was detected in the one-way ANOVA it was followed by a two-tailed Student's t-test. The alpha value was Bonferroni corrected for multiple comparisons. The comparisons were made against the same non-stressed and elevation stress cohorts but depicted in separate plots to aid clarity.
Results
One-way ANOVA followed by post hoc Tukey's HSD test showed that all the stressors significantly [F (3,15) = 35.38, p < 0.0001] increased the number of c-Fos positive cells in the NI compared to the non-stressed group (Fig. 2E ). There was no statistically significant difference among the different stress methods.
Stimulation of the HP resulted in a characteristic negative going waveform with a latency of 18-26 ms. Under normal conditions (non-stressed group), HFS of the HP induced LTP and repeated measures ANOVA indicated that the within subject effect of time was significant [F (24,120) = 11.546, p < 0.0001], and the amplitude of fEPSP post HFS at all the time points were significantly higher than the baseline field potential. A significant impairment in LTP was observed in all the stress protocols tested namely exposure to 1. cold swim for 20 min (Fig. 3A and B) , 2. swim for 30 min (Fig. 3C and D) or 3. elevated platform (Fig. 3E and F) . Two-way ANOVA of the entire, 30-min averaged, data set with time as a repeated measure and the various treatment groups (1. non-stress, 2. 20 min cold swim, 3. 30 min swim, 4. elevation stress, 5. antalarmin before elevation stress and 6. antalarmin after elevation stress) analysed between subjects showed a significant group effect [F (5,28) = 5.177, p < 0.002].
On comparing the effects of different kinds of stress against the non-stressed group at each of the 30-min time periods, twotailed Student's t-test showed that cold swim, swim and elevation stress significantly (p < 0.0001) reduced the fEPSP at all time points post HFS (Fig. 3B, D and F) . Since the elevation stress showed a robust induction of c-Fos expression in the NI and the impairment of HP-mPFC LTP, it was selected to demonstrate that antalarmin induced NI modulation effects on the HP-mPFC LTP. The results indicated a significant increase in the post HFS fEPSP amplitude in both antalarmin treatment protocols compared to the elevation stress group (Fig. 4) showing that antalarmin infusion into the NI reversed the elevation-stress induced reduction of post HFS fEPSP. One-way ANOVA comparing the non-stressed, elevation stressed and antalarmin 10 min before elevation stress groups ( Fig. 4A and B) showed significant effects in the response to HFS at T 1-30 min [F (2,17) = 6.131, p = 0.011], T 31-60 min [F (2,17) = 6.367, p = 0.010], T 61-90 min [F (2,17) = 5.567, p < 0.016]. Likewise, one-way ANOVA comparing the non-stressed, elevation stressed and antalarmin 5 min before HFS groups ( Fig. 4C and D) showed significant effects at T 1-30 min [F (2,16) Open circles represent the non-stressed group while dark gray, light gray and black markers represent antalarmin before elevation stress, antalarmin after elevation stress and elevation stress groups, respectively. The insets in the figure (A and C) show representative post HFS waveforms. The broken lines represent the non-stressed group, the black lines represent the elevation stress group, the dark gray line represents antalarmin before elevation stress group (in A) while the light gray line represents the antalarmin after elevation stress group (in C). Scale bar: 10 ms, 0.2 mV. In the right panel, (B and D) columns represent mean normalised percentage field evoked potential (fEPSP) of preceding 30 min. Open bars represent the non-stressed group while dark gray, light gray and black bars represent antalarmin before elevation stress, antalarmin after elevation stress and elevation stress groups, respectively. Error bars represent SEM. *p < 0.05 ***p < 0.001, compared to non-stressed group. p < 0.05, p < 0.001 compared to elevation stress group. Repeated measures ANOVA on the entire data set, one-way ANOVA at time points TBL, T0-30, T31-60 and T61-90 followed by Student t-test (Bonferroni corrected). Comparison with the same non-stressed and elevation stressed group is depicted in two separate plots for clarity.
Discussion
Stressors elevate c-Fos expression in the NI
c-Fos induction is an accepted measure of neuronal activation that occurs in response to neuropsychopharmacological manipulations [for reviews see (Hoffman et al., 1993; Kovacs, 1998 Kovacs, , 2008 ]. Acute or chronic presentation of stressors cause a brain region specific increase in c-Fos expression which involves multiple neurotransmitter systems (Bozas et al., 1997; Kelly et al., 2011; Keshavarzy et al., 2014; Noh et al., 2012) . Studies have examined the c-Fos induction in the NI in response to intra-ventricular CRF-infusion, stress presentation (Tanaka et al., 2005) , exposure to spontaneous alternation task (Ma et al., 2009) or antipsychotic treatments . The abundant expression of CRF 1 receptors in the NI suggests that NI could directly play a role in stress responses and it is expected that stressors could induce c-Fos in the NI. Water immersion stress or intracerebroventricular infusion of CRF (that mimics a stress response) elevated the c-Fos expression in the NI (Tanaka et al., 2005) implying the role of CRF 1 receptors. It is apparent that all the stressors employed in the present study, caused robust increases in c-Fos expression, suggesting that c-Fos expression in the NI may be a reliable marker of stress response. Unlike the differential responses reported for dorsal raphe neurons (Kelly et al., 2011) , the two variants of swim stress did not result in significantly different magnitudes of c-Fos induction in the NI. Given the heterogeneity of NI neurons, it will be interesting to determine whether there is an association between the type of stress and the subpopulation of neurons (CRF 1 receptor expressing, relaxin-3-or GABA-ergic) that respond. Although there was no statistically significant difference among the 3 kinds of stressors employed, the exposure to the elevated platform caused the greatest increase in the number of c-Fos positive cells of the NI.
NI contributes to stressor-related impairment of HP-mPFC LTP
In the present study, stressors that were shown to induce c-Fos in the NI, suppressed LTP in the HP-mPFC pathway. The HP-mPFC pathway is especially susceptible to stress since both hippocampus and prefrontal cortex are known to be structurally and functionally affected by stress (Cerqueira et al., 2007; Goldwater et al., 2009 ). In particular, elevation stress has been shown to suppress LTP in the HP-mPFC pathway (Rocher et al., 2004) and the current study extrapolates this finding to the two variants of swim stress.
Previous studies from our lab demonstrated that electrical stimulation of the NI or CRF infusion into the NI suppressed the firing of the prefrontal cortical neurons and LTP in the HP-mPFC pathway (Farooq et al., 2013) . While the NI projects to both hippocampus and medial prefrontal cortex (Farooq et al., 2013; Goto et al., 2001; Hoover and Vertes, 2007) , projection neurons from the NI to the PFC are expected to play a dominant role in the modulation of LTP in the HP-mPFC pathway (Farooq et al., 2013) . Manipulations such as electrical stimulation or CRF peptide infusion (CRF 1 receptor activation) can be perceived as simplified, or perhaps oversimplified, models of stress. Now, under the presumption that stress activates the NI via CRF 1 receptor stimulation, it is reasonable to believe that activation of the NI in response to stress could contribute to the suppression of HP-mPFC LTP. Hence, a direct antagonism of CRF 1 receptors in the NI using antalarmin, a selective CRF 1 receptor antagonist, was carried out to investigate if CRF 1 receptor activation in the NI plays a role in stress-induced suppression of HP-mPFC LTP. Antalarmin and similar non-peptide CRF 1 antagonists typically have 1000-fold selectivity for CRF 1 receptors over CRF 2 receptors (Steckler, 2015) . Many studies have employed this non-peptide CRF 1 antagonist (Webster et al., 1996) to elucidate the role of CRF 1 receptors in rodent stress models in which anatalarmin was shown to reverse stress certain responses (Banerjee et al., 2010; Djouma et al., 2006; Forbes and Cox, 2014; Takahashi et al., 2011; Wang et al., 2011) . The dose of antalarmin was selected based on the previous literature. Infusion of antalarmin (0.25 g) into amygdala decreased fear responses in stressed mice (Robison et al., 2004 ). An in vivo microdialysis study in anaesthetised rats showed that antalarmin (0.25 g) infusion into the dorsal raphe nucleus blocked the decrease in 5-HT levels in nucleus accumbens induced by CRF (Lukkes et al., 2008) . Direct infusion of antalarmin (0.25 g) into the dorsal raphe nucleus increased elevated plus maze open arm entries in isolation-reared rats (Bledsoe et al., 2011) . Meanwhile, intracerebral infusion of a substantially higher dose of 2.1 g was selective for CRF 1 receptors over CRF 2 receptors as demonstrated by selective abolition of urocortin-evoked hypertension by pretreatment with this dose of antalarmin but not by pre-treatment with the selective CRF 2 receptor anatgonist, K 41498 (Lawrence et al., 2002) .
In particular, elevation stress was selected to study the effects of CRF 1 receptor antagonism in the NI for two reasons. Firstly, elevation stress induced c-Fos expression in the NI to the greatest magnitude among the other stressors compared in the current study. Secondly, elevation stress-induced suppression of LTP was proposed as a reliable model to study stress-induced impairments in plasticity (Rocher et al., 2004) and this effect was reproducible in our laboratory. Previously, systemic pretreatment with antalarmin was shown to reverse repetitive swim stress-induced relaxin-3 mRNA expression in the NI (Banerjee et al., 2010) . The suppression of HP-mPFC LTP could involve (1) actions of CRF in the NI during the elevation stress that have a sustained effect suppressing LTP later (for example involving changes in gene expression) and/or (2) effects of CRF on the activity of the NI cells during the LTP protocol. To differentiate between these possibilities, antalarmin was infused directly into the NI in two separate designs: (1) 10 min prior to elevation stress and (2) 5 min prior to presentation of HFS. Elevation stress-induced suppression of LTP was partly reversed by intra-NI infusion of antalarmin in both treatment protocols. That both administration of antalarmin prior to elevation stress and prior to HFS (post elevation stress) partially blocked the elevation stress-induced suppression of HP-mPFC LTP indicates that both an activation of NI during the LTP protocol and a sustained effect of stress are likely involved. Although the observed effects can be attributed to the CRF 1 receptors in the NI, the effects due to diffusion of antalarmin to other structures cannot be completely ruled out. It is tempting to speculate that under conditions of stress, at least acute stress, CRF activates the CRF 1 receptors of the NI, which inhibit prefrontal cortical activity and thereby contribute to impairment of plasticity in the HP-mPFC pathway.
In summary, nucleus incertus responds to stress and influences plasticity in the HP-mPFC pathway under conditions of stress. The liaison between HP and PFC has long been implicated in various aspects of cognition (Eccles, 1986; Laroche et al., 2000; Spellman et al., 2015) and plasticity in the HP-mPFC pathway has been especially useful model to study stress-related impairments (Baudin et al., 2012; Mailliet et al., 2008; Rocher et al., 2004) . The results from the present study and those published earlier (Farooq et al., 2013) clearly suggest that CRF receptors in the NI contribute to the stress-induced impairment of plasticity in the HP-mPFC. It is thus proposed that NI-HP-mPFC connectivity forms a stress responsive ensemble in the rodent brain and that CRF 1 receptor antagonism in the NI could ameliorate stress-related impairment in cognition.
